Biden to announce 'historic partnership': Merck will help make Johnson & Johnson coronavirus vaccine
Last edited Tue Mar 2, 2021, 09:33 AM - Edit history (1)
Source: Washington Post
President Biden will announce Tuesday that pharmaceutical giant Merck & Co. will help make Johnson & Johnsons single-shot coronavirus vaccine an unusual pact between fierce competitors that could sharply boost the supply of the newly authorized vaccine, according to senior administration officials. The officials, who spoke on the condition of anonymity to discuss a matter that has not been announced, said they began scouring the country for additional manufacturing capacity after they realized in the first days of the administration that Johnson & Johnson had fallen behind in vaccine production.
They soon sought to broker a deal with Merck, one of the worlds largest vaccine makers, which had tried and failed to develop its own coronavirus vaccine. Under the arrangement, Merck will dedicate two facilities in the United States to Johnson & Johnsons shots. One will provide fill-finish services, the last stage of the production process during which the vaccine substance is placed in vials and packaged for distribution. The other will make the vaccine itself, and has the potential to vastly increase supply, perhaps even doubling what Johnson & Johnson could make on its own, the officials said.
Its a historic partnership, said one of the officials, adding that the companies recognize this is a wartime effort. He praised their sense of corporate citizenship. The officials declined to provide details about how Mercks involvement will affect the projected supply of the Johnson & Johnson vaccine and the timetable for distributing it. It could easily take two months to get the fill-finish plant ready and a few more months to equip the other facility to make the vaccine, according to a person familiar with the process who spoke on the condition of anonymity because he was not authorized to discuss the issue.
The Biden administrations efforts to ramp up production of the Johnson & Johnson vaccine suggest that it sees the vaccine playing a bigger role in addressing the challenges ahead, such as the eventual need for childrens vaccine and possibly for boosters to counter virus variants, said a person familiar with the situation who spoke on the condition of anonymity because he was not authorized to discuss it. Johnson & Johnson is conducting a trial of a two-shot vaccine, with the doses given two months apart, with results not expected until at least May. Johnson & Johnson did not respond to a request for comment. Merck did not comment on the deal but said it remains steadfast in our commitment to contribute to the global response to the pandemic.''
Read more: https://www.washingtonpost.com/health/2021/03/02/merck-johnson-and-johnson-covid-vaccine-partnership/
Full headline: Biden to announce historic partnership: Merck will help make Johnson & Johnson coronavirus vaccine, officials say
This is interesting. As far as I know, Merck has sat this out...
ETA - here is an article I found that indicated that back in January, Merck was looking at getting into the action as a partner - https://www.fiercepharma.com/pharma/merck-after-canning-covid-19-vaccine-programs-talks-to-help-shot-production
Merck canned its own COVID-19 vaccines. Now, it's in talks to manufacture other companies' shots
by Eric Sagonowsky | Feb 11, 2021 10:00am
After Merck & Co. got off to a late start in the COVID-19 vaccine race and made an early exit, the drug giant is in talks to aid the global vaccine manufacturing effort. The drugmaker is actively involved in discussions with governments, health agencies and other pharmaceutical companies to identify the areas of pandemic response where we can play a role, including potential support for production of authorized vaccines," a spokesman said via email.
News of the talks comes about two weeks after Merck abandoned both its coronavirus vaccine candidatesone it acquired through its Themis buyout and the other it was studying in partnership with IAVI. Merck said the two shots had produced immune responses weaker than those prompted by natural infections as well as by other COVID-19 vaccines.Still, the company believes it has an important responsibility to contribute to the pandemic response," the spokesman said, and remains "at the ready to do so."
While Merck hasn't indicated which companies it could help with production, there has been industry talk about a potential tie-up with Novavax. After the vaccine biotech last month presented positive phase 3 data on its candidate, Evercore ISI analyst Josh Schimmer said he suspected Merck might "step up" as Novavax's manufacturing partner. Novavax CEO Stan Erck then told CNBC's Meg Tirrell that Merck "could be a good partner for us as they don't have a competing product." He also named GSK as a company with those capabilities. At the time, Merck told Tirrell it was focused on therapeutics.
(snip)
Also this week, Teva said it was in talks to help with COVID-19 vaccine production. The company has sites in Israel, Europe and the U.S. that could be used in the global effort, CEO Kåre Schultz said, according to The Wall Street Journal.
Auggie
(31,061 posts)BumRushDaShow
(127,301 posts)Auggie
(31,061 posts)Merck recoups some of the money spent on R&D. Smart business move.
2naSalit
(86,054 posts)NJCher
(35,426 posts)Happy to wake up to this.
I wonder if some of the manufacturing will be done here in nj. We are the nations pharmaceutical capitol.
🧪. 💊. 🔬. 💉.
BumRushDaShow
(127,301 posts)than their pharmaceuticals. They already had plans to expand their large NC campus for other vaccines and therapeutics that they do and and had been looking at other states for vaccine production (article from 2019) - https://www.pharmaceuticalonline.com/doc/merck-new-manufacturing-facility-north-carolina-support-hpv-vaccine-production-0001
lkinwi
(1,477 posts)Arkansas Granny
(31,483 posts)Botany
(70,291 posts)Nice to see this news.
bucolic_frolic
(42,672 posts)You can have the vaccine formulae, you can have distribution, you can have the money to pay for it, but you must have the manufacturing capacity. Whether its the Defense Production Act or just brokering a deal, this is great news, not just for the US but for the world.
Response to BumRushDaShow (Original post)
Post removed
BumRushDaShow
(127,301 posts)to determine if there is increased efficacy.
Bear Creek
(883 posts)It should not have been approved.
BumRushDaShow
(127,301 posts)They simply have "Emergency Use Authorization".
The flu vaccines are "approved". The polio vaccines are "approved". The COVID-19 vaccines are not "approved".
Bear Creek
(883 posts)This one has proven not be be as good and until it can prove to have the same results needs to be on hold.
BumRushDaShow
(127,301 posts)and that is at least 50% effective. COVID-19 vaccine guidance (FDA PDF).
No vaccine is 100 percent effective, but some work better than others.
Nov. 3, 2020, 4:58 AM EST
By Jacqueline Stenson
Over the summer, the Food and Drug Administration announced that in order for an experimental Covid-19 vaccine to get the green light, it would need to be safe and prevent disease or decrease its severity in at least 50 percent of people who are vaccinated.
In fact, no vaccine is 100 percent effective, but some work better than others. One of the most successful is the measles vaccine two doses are 97 percent effective in preventing the disease, according to the Centers for Disease Control and Prevention. Still, 50 percent sounds like a far cry from 97 percent.
I know that 50 percent does sound low but that is still some protection, and some protection is better than no protection, said Dr. Jeff Kwong, professor of public health and family medicine and interim director of the Centre for Vaccine Preventable Diseases at the University of Toronto.
Based on the effectiveness threshold the FDA has set for a Covid-19 vaccine to be approved or granted emergency use authorization, its possible a vaccine becomes available that helps only half of people receiving it, while offering no benefit to the other half. Its also possible that a vaccine could have different effects in different people helping to prevent disease in some people while reducing the severity of Covid-19 in others.
https://www.nbcnews.com/health/health-news/fda-s-cutoff-covid-19-vaccine-effectiveness-50-percent-what-n1245506
Even with the annual flu vaccine(s), you are lucky to get 50 - 60% effectiveness if they can target the right ones that will end up in circulation here in the northern/western hemisphere.
Here is the general process for vaccine development - https://www.fda.gov/vaccines-blood-biologics/development-approval-process-cber/vaccine-development-101
tinrobot
(10,848 posts)The vaccine was tested at a later time under different conditions than the 2 shot vaccines. This was at a point in time where the virus was raging. It was also tested in South Africa, where the variants are spreading.
It has proven to be highly effective against severe cases, hospitalization, and death.
Response to tinrobot (Reply #23)
Post removed
tinrobot
(10,848 posts)If the J&J vaccine was not effective, it would not have been approved.
Here's a more in-depth analysis of the different ways the vaccines were tested:
https://www.statnews.com/2021/02/02/comparing-the-covid-19-vaccines-developed-by-pfizer-moderna-and-johnson-johnson/
But comparing the efficacy of those vaccines to the efficacy of Johnson & Johnsons is challenging because of differences in the designs of the Phase 3 clinical tests essentially the trials were testing for different outcomes. Pfizers and Modernas trials both tested for any symptomatic Covid infection. Pfizer started counting cases from seven days after receipt of the second dose of vaccine, while Moderna waited until day 14 to start counting cases.
J&J, by contrast, sought to determine whether one dose of its vaccine protected against moderate to severe Covid illness defined as a combination of a positive test and at least one symptom such as shortness of breath, beginning from 14 or 28 days after the single shot. (The company collected data for both.)
Because of the difference in the trials, making direct comparisons is a bit like comparing apples and oranges. Additionally, Pfizer and Modernas vaccines were tested before the emergence of troubling new variants in Britain, South Africa, and Brazil. Its not entirely clear how well they will work against these mutated viruses.
Different vaccines, tested differently in different places at different times. ALL of them provided excellent protection against severe disease and death. Spreading misinformation does not help get us through this.
TwilightZone
(25,342 posts)This is a patently false statement.
FBaggins
(26,696 posts)We do not actually know that it "does not provide the protection" that the other vaccines provide. You see a moderately lower percentage and assume that you know what it means and can compare the two... but it isn't "apples to apples".
There are many reasons to believe that this option could be better overall than the existing two vaccines approved for emergency use.
Bear Creek
(883 posts)Been shown. The 2 companies involved have dubious business practices. J & J with the opiate emergency and Merck with pushing drug for not approved use.
FBaggins
(26,696 posts)Your concerns re: their business practices or other drugs that they manufacture have exactly nothing to do with how effective their vaccine is relative to the other two currently on the list and/or whether it makes sense for the new offering to be included beside them.
TwilightZone
(25,342 posts)lagomorph777
(30,613 posts)Deminpenn
(15,246 posts)whose trials took place before the many mutations began to appear.
SheltieLover
(57,073 posts)Not sure why anyone would want more of the less effdctive vaccine?
Maybe manufacturing issues. Dunno.
Bear Creek
(883 posts)This makes me wonder who they are going to target as the customer for this vaccine.
SheltieLover
(57,073 posts)1st article I saw on this approval said great for rural areas & sailors - people who might not present for 2nd dose for various reasons.
There might well be issues I am not aware of, but upping production of vaccines with much higher efficacy would seem to be a smarter choice.
It sounds like dumming down the vax process from where I'm sitting.
All that said, I do trust Joe's judgment.
BumRushDaShow
(127,301 posts)SheltieLover
(57,073 posts)BumRushDaShow
(127,301 posts)Remember that there is NO COVID-19 vaccine "approved for normal use". All of them ONLY have "Emergency Use Authorization" due to the severity of this terrible pandemic.
So you are seeing something a bit unprecedented because of the fast-track nature to allow the mass vaccinations in order to try to get a handle on this virus since lockdowns and other measures like mask-wearing, are obviously not working well.
Over time, there will be MUCH "tweaking" of all of them and the trials are continuing. In fact as I understand, they are all also working on alterations and/or boosters to deal with the variants. That is what happens yearly with the flu vaccine.
Each year they look at which variants of Influenza are circulating in Asia/Australia and then try to estimate/guess which ones may end up being prevalent here and will select those to come up with a vaccine to use in the annual flu shot. In many cases, the guesses "fail".
For example as reported at the beginning of 2020, CDC released their report on the 2019 flu vaccine effectiveness as reported here -
February 26, 2020 10:01 am Chris Crawford -- According to a Feb. 21 CDC Morbidity and Mortality Weekly Report, the current influenza vaccine has been 45% effective overall against 2019-2020 seasonal influenza A and B viruses.
Specifically, the flu vaccine has been 50% effective against influenza B/Victoria viruses and 37% effective against influenza A(H1N1)pdm09.
According to former AAFP Vaccine Science Fellow John Epling, M.D., M.S.Ed., of Roanoke, Va., that means the vaccine is about as effective as it typically is in a season when it offers a decent match to circulating influenza antigens.
"The meaning of the effectiveness number gets misinterpreted frequently," he told AAFP News. "While we would all want an even more effective vaccine, it remains the best way we have to prevent flu and its complications."
https://www.aafp.org/news/health-of-the-public/20200226interimfluve.html
Response to SheltieLover (Reply #18)
Post removed
ForgoTheConsequence
(4,846 posts)Good Lord.
BumRushDaShow
(127,301 posts)(meaning that's it for any more posting in this thread)
ForgoTheConsequence
(4,846 posts)Pretty vulgar to assume that our President is allowing a lesser vaccination because of campaign contributions. You can have conversations about things without wading into conspiracy theories or outside of your area of understanding.
BumRushDaShow
(127,301 posts)It hasn't even been a year since they started working on this. Most of the initial trial phases didn't even start until around May or so.
But consider two other things -
1.) This vaccine is a more "traditional" type that utilizes some type of viral material to trigger the body's antibody reaction versus the novel way (using messenger RNA a/k/a "mRNA" ) to do the same as attempted by Pfizer & Moderna (i.e., which don't use any viral material at all). What Janssen/J&J has done is pretty much how EVERY other vaccine is developed. They seemed to have a better outcome than GSK/Sanofi's attempt or even Merck's attempt using the "traditional" method.
2.) Vaccines like the flu vaccines don't have the type of effectiveness as being demanded for these. You are lucky to get 60% out of an annual flu vaccine.
SheltieLover
(57,073 posts)I'm sure they are going for herd immunity but, as an individual, I would be furious if someone tried go get me to take the less effective one. Or if that were the only vax available...
Just trying to understand.
Again, this must be a good decision or else Joe wouldn't have brokered the deal.
BumRushDaShow
(127,301 posts)https://www.democraticunderground.com/?com=view_post&forum=1014&pid=2704908
I know they keep using that damn term "herd immunity" but we have never had "herd immunity" with stuff like "the common cold" or "the flu" (which is what this is closer to) vs polio or measles or chicken pox, and it really gets my goat for them to keep repeating that term. Respiratory viruses are hard to deal with vs other viruses like the ones mentioned or tetanus, Hepatitis, or HPV, etc.
This virus may have to be taken care of like we do with the flu shot (a yearly booster thing).
As I understand it after watching FDA/CBER's Vaccine Advisory Committee meeting last Friday, they are trialing what happens with a 2nd dose of this vaccine.
SheltieLover
(57,073 posts)You are very kind to share!
BumRushDaShow
(127,301 posts)We are gonna be stuck with this for awhile, just like how the "bird flu" (H5N1) and the "swine flu" (H1N1 - a variant of which caused the 1918 Flu pandemic) pop up every once in awhile... although neither of those were as virulent as this, and this isn't even as bad as something like Ebola, which is fortunately not as widespread or prevalent because it's not a "respiratory" virus like COVID-19).
SheltieLover
(57,073 posts)lagomorph777
(30,613 posts)So don't go assuming that J&J is, in reality, less effective.
It also has some massive advantages:
Single Dose.
Simple Storage and shipment.
Bear Creek
(883 posts)What that is what has been shown.
ForgoTheConsequence
(4,846 posts)Misinformation that could be harmful and confusing. You're not an immunologist or epidemiologist, stay in your lane and stop spreading Facebook like misinformation.
Tommymac
(7,263 posts)If there is money to be made, the actual benefit to the common person is secondary.
I am a staunch Democrat, but I do recognize that Our party has it's corporate side too. Fortunately, We the People can still have a say, unlike the Authoritarian QOP Party.
BumRushDaShow
(127,301 posts)vaccines are NOT a money-maker and that is why they rarely get into the manufacturing of them, usually only when countries beg them to make them (and probably offer subsidies and other incentives to do so).
What happened with COVID-19 seems to have changed the whole equation and business model due to the severity of the diseases it causes, the fatality rate that is higher than other very prevalent viruses (like Influenza), and how widespread it has been. So now you will see more and more jumping on the bandwagon - which because of the virulence of this virus, is good. But it is also unfortunate because just plain common sense measures like wearing a damn mask, have failed.
lagomorph777
(30,613 posts)Merck has idle capacity to exploit, after their failed project. J&J will surely collect royalties. And the public gets more shots.
House of Roberts
(5,120 posts)President Biden said Thursday that his administration had finalized deals for another 200 million doses of the two coronavirus vaccines authorized in the United States, giving the country enough vaccine by the end of July to cover every American adult.
Every American adult. Why are all the administration officials working so hard to sell the public on this Johnson and Johnson vaccine? I always become skeptical when I get the high pressure pitch on anything. On Sunday, Fauci and every other medical expert went overboard to convince people the J&J vaccine was just as good as Pfizer and Moderna. It's not. I worry we're having our expectations lowered to accept less as good enough.
lagomorph777
(30,613 posts)Totally unfair comparison.
House of Roberts
(5,120 posts)COMPARED to the earlier strain?
Moderna has tested their vaccine against the new variants, as soon as they were discovered, and are prepared to produce booster shots as needed. As of a month ago, they weren't needed.
The RNA based vaccine can be re-engineered much more quickly to counter new strains than the DNA based.
lagomorph777
(30,613 posts)Also, I don't run the tests.
BumRushDaShow
(127,301 posts)If you scroll down, there are links to all of the presentation slides (including their trial data and reported adverse effects, etc).
This slide (PDF) has info on this vaccine in general including the variants - https://www.fda.gov/media/146218/download
This one (PDF) also discusses the types and prevalence of the variants - https://www.fda.gov/media/146264/download
There is also recording of the entire session (I watched the whole thing from 9am ET until almost 5:30 pm ET on 2/26/21) -
One of the Vaccine Advisory Board members is located here in Philly (Dr. Dr. Paul Offit who is currently Director of Philadelphia's Children's Hospital Vaccine Education Center and also a co-inventor of a rotavirus vaccine).
Tommymac
(7,263 posts)Thanks.
lagomorph777
(30,613 posts)https://abcnews.go.com/Politics/single-dose-johnson-johnson-vaccine-effective-variants-data/story?id=76084549
https://heavy.com/news/johnson-johnson-moderna-pfizer-covid19-vaccine-comparisons/
https://abcnews.go.com/Health/latest-johnson-johnson-covid-vaccine-data-means/story?id=76092851
BumRushDaShow
(127,301 posts)In general, "vaccines" are loss-leaders for big pharma so they usually have to be begged to "please please make some" because they make little or no money on them.
So many of the "big boys" sat this out and smaller companies like Moderna (or some of the subsidiaries of the bigger companies and/or partnerships like Pfizer did) were working on some after the ugly predecessor virus SARS-CoV-1 (commonly called "SARS" in 2003) - possibly so they could exploit the Asian market with a vaccine. But their doing that actually helped to get them in on the ground floor of development early on and thus in position to be ready to go with some vaccine candidates so they could set up trials very quickly.
Meanwhile the "big boys" like Merck and J&J and GSK sortof sat back or tried some halting efforts until they facepalmed with an "Oh shit!" and realized they were now missing out on not just one or two continents' cha-chings, but the WHOLE world's CHA-CHING - $$$$$$$$$!
So here we are.
I expect some of the push (although this vaccine is actually being made by a J&J subsidiary Janssen Pharmaceuticals which is HQ'd in Belgium) is that J&J is an "American company".
h2ebits
(632 posts)This is a pandemic that we are dealing with and we have worldwide shortages of vaccines to fight it off. A number of countries have not received any--or minimal--amounts of vaccine.
Biden boosted production by invoking the National "whatever it is called" Act and now the big production numbers will help boost worldwide coverage of the vaccines.
Science, ingenuity, pharma companies stepping up to share production facilities around the world, logistical distribution--helping each other globally to fix a GLOBAL problem.
It makes me so happy to read the news that you shared. THANK YOU!
BumRushDaShow
(127,301 posts)Defense Production Act (codified in 50 USC Ch. 55)
60 million more at-home tests will be available by end of summer, administration says
By Ariel Cohen
Posted February 5, 2021 at 3:24pm
The White House COVID-19 task force announced Friday that the Biden administration plans to use the Defense Production Act to ramp up manufacturing of COVID-19 vaccines, surgical gloves and at-home testing kits as part of an effort to increase supplies and reduce long-term dependence on foreign suppliers. The administration said it will use the DPA to contract with six more COVID-19 at-home test suppliers, which should result in more than 60 million at-home tests becoming available by the end of the summer.
This news comes just days after the administration announced a $231.8 million deal with at-home COVID-19 test-maker Ellume to produce 100,000 test kits per month for the United States from February to July, with a goal of ramping that number up to 19 million tests per month by the end of the year. The COVID-19 task force did not yet disclose who makes the tests or how much the tests will cost, as the contracts aren't final. COVID-19 Response Team Supply Coordinator Tim Manning said the U.S. would work with these companies to construct new domestic plants and production lines.
The administration also plans to help Pfizer ramp up its COVID-19 vaccine production by expanding the priority rating on Pfizer's vaccine production contract to ensure the drugmaker gets first dibs on specific products and materials it needs to produce vaccines. This will now include filling pumps and tangential flow filtration skid units, two critical components of vaccine manufacturing. This action should have an immediate impact, officials said. This move could help Pfizer reach its production goals of delivering 200 million doses of its COVID-19 vaccine to the U.S. by May. Since Jan. 20, the new administration has increased vaccine supplies to states by more than 20 percent. Right now, one of the factors restraining manufacturing is limited equipment and ingredients, Manning said.
Finally, the administration said it will leverage the DPA to increase the production of surgical gloves, something the country needs more of now. Currently, the U.S. is nearly completely reliant on overseas manufacturers of surgical gloves, Manning said. So, the United States will build plants to produce the raw materials for surgical gloves so they can be produced in the U.S. By the end of the year, the administration hopes to make 1 billion nitrile gloves per month in the U.S, although this will satisfy only half of the country's demand for surgical gloves. Due to procurement law restrictions, the task force cannot say who it is contracting with until the contracts are finalized. Manning said the contracts usually take about four to five weeks to finalize and officials are roughly halfway through the process, so more details are expected to be released in the coming weeks.
https://www.rollcall.com/2021/02/05/biden-to-use-defense-production-act-for-gloves-covid-19-vaccines/
Yo_Mama_Been_Loggin
(107,085 posts)Instead he put boy blunder Jared in charge of everything.
BumRushDaShow
(127,301 posts)that now sit unused. The NEED was for masks and gloves and other PPE (which is still a need)... but...Jared.
By Faiz Siddiqui
August 18, 2020 at 7:00 a.m. EDT
SAN FRANCISCO Months into a $3 billion U.S. effort to manufacture tens of thousands of ventilators to stave off coronavirus deaths, the government stockpile is facing a glut. General Motors and Ford by early May began delivering the first ventilators they scrambled to manufacture, in part compelled by President Trumps invocation of the federal Defense Production Act. General Electric, Philips and other manufacturers efforts have delivered more than 94,000 of them to the stockpile, and General Motors plans to soon hand over its business to a counterpart.
During the first weeks of the covid-19 crisis in March, health officials panicked over an anticipated shortage of ventilators, breathing machines that were essential to help keep patients alive. But during the months it took for companies to develop their supply chains, test prototypes and train workers to build them, the approach to treating covid-19 changed. Now, unexpectedly, the vast majority of ventilators are going unused. The Department of Health and Human Services said it had handed out 15,057 ventilators by Friday, and there were 95,713 ventilators in the federal stockpile. Of those, 94,352 came from contracts signed since the beginning of the pandemic.
In the fog of war against the virus, we were trying to do our best to protect the health and safety of the American people, said Peter Navarro, White House trade adviser and Defense Production Act policy coordinator. In this particular chess game, the best move was to make sure we had too many ventilators rather than too few. Navarro said that excess ventilators will be used to help other countries fighting the novel coronavirus, either as revenue-generating exports or as donations.
The misalignment between the availability and need for ventilators shows that the medical understanding of and response to the coronavirus has moved faster than companies can adapt. And for Ford, which got the order to supply the largest quantity of ventilators to the federal stockpile, production and delivery were delayed, further throwing it out of sync with the pandemic needs.
https://www.washingtonpost.com/business/2020/08/18/ventilators-coronavirus-stockpile/
Steelrolled
(2,022 posts)There were daily stories from NYC and Italy about ventilator numbers, and how doctors were going to have to decide who gets a ventilator and who dies.
The "fog of war" is an apt metaphor - the medical establishment didn't really know the best treatments and were learning as they went.
I have learned a little about what I should and shouldn't expect from the medical establishment. Everyone is working more-or-less towards the goal, but human nature causes detours.
BumRushDaShow
(127,301 posts)my concern was them using the car companies vs using vacuum companies like Dyson (which had started making them in the UK), as they could be ready to roll much faster. So time was wasted trying to come up with designs and training, etc., to force-fit this type of product within companies that really didn't have that type of expertise as part of their base product lines.
And yes I recall when NY was going through their peak nightmare number of cases early on and the shortage of ventilators issue, so there was a real need. But had they made a better decision on WHO would make them, then what eventually turned out to have been a short-term need, could have been filled faster.
Steelrolled
(2,022 posts)but in my career there have been cases where the "answer is known" whether you believe in it or not, and you just do it.
I imagine there were voices in the wilderness saying we aren't going to need all those ventilators, but of course they were in the wilderness.
h2ebits
(632 posts)Thanks for updating it for me.
BumRushDaShow
(127,301 posts)BobTheSubgenius
(11,535 posts)This does have more than a slight tinge of the WW2 manufacturing efforts. WW1, for that matter. Did you know that a campaign to conserve steel for the war effort was a major factor in the switch from corsets to bras? Also, the constriction of corsets made them totally unsuitable for the new phenomenon of women in large numbers working in factories.
But I digress.
It unnerved me a little to read that phrase "Merck...tried and failed." It seems unlikely that they just could not manage it, but more that they decided they'd missed the window. Could be dead wrong, of course.
Something for which we really need more information to make a better judgment is the months it's going to take Merck to get up to speed. If you listen to politicians and public health authorities, it sounds to me that the massive vaccination effort will be well on its back end by the time Merck ships a single box. The time frame indicated in this article is at least 5 months, which is pretty concurrent with the level of vaccinations considered to be needed to have curbed this menace.
Is there something I've missed in that timeline? The start of the New Eras in both governance and pandemic eradication have got off to spectacular starts. Is this pace going to outstrip supply in the near future?
Jon King
(1,910 posts)Another day of a federal government working for the people, all the people.
Yo_Mama_Been_Loggin
(107,085 posts)Seriously, Trump was advised to invoke the Defense Production act to speed up PPE production and vaccine research. Instead he put boy blunder Jared in charge of everything.
mwooldri
(10,291 posts)Sanofi tried to make their own, didn't do so well. Their plants in Europe will be helping make and distribute the Pfizer / BioNTech vaccine.
https://www.sanofi.com/en/media-room/press-releases/2021/2021-01-27-07-30-00
BumRushDaShow
(127,301 posts)and hoped to have something by the end of this year...
Bayard
(21,805 posts)Two of the biggest pharma companies in the industry--and major competitors--joining forces for the greater good. I'm sure they'll get paid handsomely for their cooperation, but the effort to bring these two together deserves major accolades.
Wonder if Merck will continue manufacturing their own products in other areas of the plants. Brand security is a major concern.
BumRushDaShow
(127,301 posts)Vaccines are usually a tiny part of what the big companies do and when the have gone through their buying sprees, they will often buy up smaller companies to do targeted products (under their name) like vaccines or orphan drugs, etc.
SharonClark
(10,005 posts)And, yes, this is a good thing. Every person vaccinated is a victory.
oasis
(49,151 posts)mpcamb
(2,855 posts)We need a lot of grains of salt.